Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
44.74
+0.46 (1.04%)
May 20, 2026, 9:33 AM EDT - Market open

Novo Nordisk Income Statement

Millions DKK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
327,800309,064290,403232,261176,954140,800
Revenue Growth (YoY)
8.13%6.43%25.03%31.25%25.68%10.91%
Cost of Revenue
59,49658,78844,52235,76528,44823,658
Gross Profit
268,304250,276245,881196,496148,506117,142
Selling, General & Admin
67,38470,27967,37761,59850,68441,058
Research & Development
52,01552,03948,06232,44324,04717,772
Other Operating Expenses
4203002,103-119-1,034-332
Total Operating Expenses
119,819122,618117,54293,92273,69758,498
Operating Income
148,485127,658128,339102,57474,80958,644
Interest Income
12,2889,6606,1982,9452392,887
Interest Expense
-5,094-6,778-7,346-845-5,986-2,451
Total Non-Operating Income (Expense)
7,1942,882-1,1482,100-5,747436
Pretax Income
155,679130,540127,191104,67469,06259,080
Provision for Income Taxes
33,72228,10626,20320,99113,53711,323
Net Income
121,957102,434100,98883,68355,52547,757
Net Income to Common
121,957102,434100,98883,68355,52547,757
Net Income Growth
16.58%1.43%20.68%50.71%16.27%13.33%
Shares Outstanding (Basic)
4,4454,4434,4544,4834,5314,593
Shares Outstanding (Diluted)
4,4484,4484,4634,4954,5454,606
Shares Change (YoY)
-0.20%-0.34%-0.71%-1.10%-1.34%-1.58%
EPS (Basic)
27.4523.0622.6718.6712.2610.40
EPS (Diluted)
27.4123.0322.6318.6212.2210.37
EPS Growth
16.74%1.77%21.54%52.37%17.84%15.16%
Shares Outstanding
4,4654,4654,4424,4584,5014,579
Free Cash Flow
88,38658,96273,80483,10266,74148,665
Free Cash Flow Growth
49.90%-20.11%-11.19%24.51%37.14%5.50%
Free Cash Flow Per Share
19.8713.2616.5418.4914.6910.57
Dividends Per Share
11.70011.70011.4009.4006.2005.200
Dividend Growth
-2.63%21.28%51.61%19.23%14.29%
Gross Margin
81.85%80.98%84.67%84.60%83.92%83.20%
Operating Margin
45.30%41.30%44.19%44.16%42.28%41.65%
Profit Margin
37.20%33.14%34.78%36.03%31.38%33.92%
FCF Margin
26.96%19.08%25.41%35.78%37.72%34.56%
EBITDA
170,173149,640147,446111,98782,17164,669
EBITDA Margin
51.91%48.42%50.77%48.22%46.44%45.93%
EBIT
148,485127,658128,339102,57474,80958,644
EBIT Margin
45.30%41.30%44.19%44.16%42.28%41.65%
Effective Tax Rate
21.66%21.53%20.60%20.05%19.60%19.17%
Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q